Cemex Sab De CV is a building material company located in Mexico, which is part of the Basic Materials sector, and is traded under the ticker CX on the NYSE exchange.
Cemex Sab De CV stock last closed at $11.51, up 2.86% from the previous day, and has increased 106.27% in one year. It has overperformed other stocks in the Building Materials industry by 1.14 percentage points. Cemex Sab De CV stock is currently +135.38% from its 52-week low of $4.89, and -0.52% from its 52-week high of $11.57.
As of Dec 12, 2025, there are 14.51B shares of CX outstanding. The market cap of CX is $16.70B. In the last 24 hours, 7.98M CX shares were traded.
How to Buy Cemex Sab De CV Stock
Not sure how to invest in Cemex Sab De CV stock? Here's how.
Figure out where to buy Cemex Sab De CV stock: You need to pick an online brokerage, but don't worry - we've tried dozens of stock brokerages and apps to help you decide where to buy Cemex Sab De CV stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your investment account: Pick your payment method and add your info.
Evaluate Cemex Sab De CV stock: The Cemex Sab De CV ticker symbol is CX. Is Cemex Sab De CV stock a good investment? Should you buy shares of CX? How do CX's underlying business fundamentals look? Do top analysts think Cemex Sab De CV is a good buy? Why has CX's stock price moved recently? (Hint: Our stock analysis website can help you understand if CX is a good stock to buy).
Place your CX trade: Decide if you will purchase CX shares at the current market price or use a limit order to buy CX stock at a particular price.
Get updates on your investment in CX: Create a watchlist to get live updates on your investment in Cemex Sab De CV stock.
Step 1: Figure out where to buy Cemex Sab De CV stock
You will need an online brokerage account to access the NYSE market and buy CX shares.
A brokerage account enables you to buy and sell a number of investments, such as stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
In our opinion, eToro is the best brokerage. eToro gives you:
Invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
Access to global markets: From Tech to Industrials, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your stock purchase by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've chosen the right brokerage, you need to fill out some personal info so you can buy CX stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Cemex Sab De CV stock
After you have figured out the best place to buy Cemex Sab De CV stock, it's important to evaluate their stock before you buy, so you truly comprehend the risk as well as the upside.
Cemex Sab De CV Numbers
CX Price
$11.51
1w %
6.28%
1y %
106.27%
5y %
119.66%
P/E
53.04x
P/B
1.37x
P/S
1.03x
PEG
N/A
Revenue
$16.20B
Earnings
$939.00M
Fore. Rev. Growth
3.95%
Fore. Earn. Growth
-24.26%
Market Cap
$16.70B
Next Earnings
Feb 5, 2026
Next Dividend
N/A
Fundamentals of Cemex Sab De CV
WallStreetZen was designed to help part-time investors perform better fundamental analysis.
You can view all of the due diligence checks on CX's stock page.
How is CX stock valued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge CX's intrinsic value.
Using relative valuations metrics:
CX could be overvalued based on its P/E ratio of 53.04x, relative to Building Materials industry P/E ratio of 26.85x
CX may be undervalued based on its P/B ratio of 1.37x, relative to Building Materials industry P/B ratio of 3.03x
You can access additional valuation analysis on CX's stock here.
CX Financial Health Summary
Pros:
Total CX debt is lower than 5 years ago, relative to shareholder equity.
CX profit margin has gone up from 1.1% to 5.8% in the past year.
CX's operating cash flow of $1.89B allows it to safely service it's debt of $7.36B.
Cons:
There are more short-term liabilities than short-term assets on the CX balance sheet.
CX earnings of $1.56B is not enough to cover its interest payments.
CX has a relatively high debt to equity ratio of 1.22.
There are more long-term liabilities than short-term assets on the CX balance sheet.
Is Cemex Sab De CV stock a Buy, Hold, or Sell, according to analysts?
Out of 7 sell side analysts who monitor CX, the consensus analyst rating on CX is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest CX Analyst Upgrades/Downgrades
Andres Cardona, a top 39% analyst from Citigroup downgrades CX to a hold rating and raises their CX price target from $9.00 to $10.00, on Oct 13, 2025.
Adrian Huerta, a top 24% analyst from JP Morgan upgrades CX to a strong buy rating and raises their CX price target from $8.10 to $10.50, on Aug 26, 2025.
JP Morgan's Adrian Huerta upgraded their rating on Cemex Sab De CV (NYSE: CX) from Hold to Strong Buy on 2025/08/26. The analyst also raised their price target by 29.6% from $8.1 to $10.5.
Huerta contextualized their upgrade of the stock and price target hike on Cemex, S.A.B. de C.V. by saying that the company's new CEO "brings to the table long-awaited transformational change at a time when the stock is trading at the low-end of its historical valuation range.
With improved prospects for Cemex's two largest markets, Mexico and the U.S., the stock should continue to re-rate higher, the analyst predicted.
Their new price target of $10.50, up from $8.10, implies 18% upside potential, Huerta noted.
Last year, CX earnings were $939.00M. In the past 5 year, CX's earnings have gone up by 47.58% per year. This was faster than the Building Materials industry average of 11.17%.
Last year, CX revenue was $16.20B. During the last 5 year, CX's revenue has gone up by 4.57% per year. This was slower than the Building Materials industry average of 6.83%.
No, Cemex Sab De CV doesn't provide an income stream by paying out dividends.
What do other traders have to say about CX?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Place your CX trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are generally the best for newer investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to be certain you're buying or selling at an exact price limit, place a limit order.
Click the Open button and eToro will place your order.
If you need additional assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Cemex Sab De CV share?
As of Dec 12, 2025, it costs $11.51 to buy one share of Cemex Sab De CV stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.434 shares of CX.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.